HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion.

Abstract
The free radical scavenger 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone) has been used to treat acute brain infarction in Japan since 2001. To obtain direct evidence that edaravone serves as an antioxidant in vivo, four groups of rats were prepared: (i) an ischemia/reperfusion (I/R) group receiving 2 h occlusion-reperfusion of the middle cerebral artery; (ii) a single administration group treated by intravenous infusion of edaravone (3 mg/kg) immediately after I/R; (iii) a repeated treatment group receiving twice daily edaravone administration for 14 days; and (iv) a sham operation group without occlusion. Repeated treatment with edaravone significantly improved the neurological symptoms and impairment of motor function as compared to the I/R group, while single administration demonstrated limited efficacy. No significant differences in plasma antioxidants such as ascorbate, urate, and vitamin E, or in redox status of coenzyme Q(9) were observed among the four groups. In contrast, the plasma content of oleic acid in the total free fatty acids (percentage 18:1) was significantly increased in the I/R group for 7 days as compared to the sham operation group. Oleic acid was produced from stearic acid by the action of stearoyl-CoA desaturase to compensate for the oxidative loss of polyunsaturated fatty acids. The above results suggest that cellular oxidative damage in the rat brain is evident for at least 7 days after I/R. Repeated treatment suppressed the percentage 18:1 increment, while the single administration did not, which is consistent with the limited efficacy of single administration.
AuthorsYorihiro Yamamoto, Makoto Yanagisawa, Nyou Wei Tak, Kazutoshi Watanabe, Chizuko Takahashi, Akio Fujisawa, Misato Kashiba, Masahiko Tanaka
JournalRedox report : communications in free radical research (Redox Rep) Vol. 14 Issue 6 Pg. 251-8 ( 2009) ISSN: 1743-2928 [Electronic] England
PMID20003710 (Publication Type: Journal Article)
Chemical References
  • Antioxidants
  • Biomarkers
  • Free Radical Scavengers
  • Oleic Acid
  • Edaravone
  • Antipyrine
Topics
  • Animals
  • Antioxidants (chemistry, pharmacology)
  • Antipyrine (analogs & derivatives, chemistry, pharmacology)
  • Biomarkers (blood)
  • Brain (drug effects, pathology)
  • Brain Ischemia (pathology)
  • Edaravone
  • Free Radical Scavengers (chemistry, pharmacology)
  • Humans
  • Infarction, Middle Cerebral Artery (metabolism, pathology)
  • Male
  • Molecular Structure
  • Neuropsychological Tests
  • Oleic Acid (blood)
  • Oxidation-Reduction
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: